Go Pro

Quanterix (QTRX) Competitors

Quanterix logo
$4.44 +0.12 (+2.78%)
As of 10:15 AM Eastern
This is a fair market value price provided by Massive. Learn more.

QTRX vs. SIBN, FEIM, CTKB, OPTX, and MASS

Should you buy Quanterix stock or one of its competitors? MarketBeat compares Quanterix with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Quanterix include SiBone (SIBN), Frequency Electronics (FEIM), Cytek Biosciences (CTKB), Syntec Optics (OPTX), and 908 Devices (MASS).

How does Quanterix compare to SiBone?

Quanterix (NASDAQ:QTRX) and SiBone (NASDAQ:SIBN) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings.

Quanterix presently has a consensus target price of $4.00, suggesting a potential downside of 9.91%. SiBone has a consensus target price of $23.00, suggesting a potential upside of 35.59%. Given SiBone's stronger consensus rating and higher probable upside, analysts plainly believe SiBone is more favorable than Quanterix.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Quanterix
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
SiBone
1 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.71

SiBone has a net margin of -8.10% compared to Quanterix's net margin of -71.86%. SiBone's return on equity of -9.56% beat Quanterix's return on equity.

Company Net Margins Return on Equity Return on Assets
Quanterix-71.86% -23.92% -17.66%
SiBone -8.10%-9.56%-7.06%

86.5% of Quanterix shares are owned by institutional investors. Comparatively, 98.1% of SiBone shares are owned by institutional investors. 1.5% of Quanterix shares are owned by company insiders. Comparatively, 3.9% of SiBone shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

SiBone has higher revenue and earnings than Quanterix. SiBone is trading at a lower price-to-earnings ratio than Quanterix, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Quanterix$138.90M1.51-$107.15M-$2.36N/A
SiBone$200.93M3.74-$18.90M-$0.39N/A

Quanterix has a beta of 1.14, suggesting that its stock price is 14% more volatile than the broader market. Comparatively, SiBone has a beta of 0.7, suggesting that its stock price is 30% less volatile than the broader market.

In the previous week, Quanterix had 1 more articles in the media than SiBone. MarketBeat recorded 2 mentions for Quanterix and 1 mentions for SiBone. SiBone's average media sentiment score of 1.87 beat Quanterix's score of 0.94 indicating that SiBone is being referred to more favorably in the news media.

Company Overall Sentiment
Quanterix Positive
SiBone Very Positive

Summary

SiBone beats Quanterix on 13 of the 16 factors compared between the two stocks.

How does Quanterix compare to Frequency Electronics?

Frequency Electronics (NASDAQ:FEIM) and Quanterix (NASDAQ:QTRX) are both small-cap measuring and control equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, profitability, valuation, earnings, institutional ownership and risk.

58.6% of Frequency Electronics shares are owned by institutional investors. Comparatively, 86.5% of Quanterix shares are owned by institutional investors. 28.0% of Frequency Electronics shares are owned by company insiders. Comparatively, 1.5% of Quanterix shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Frequency Electronics has a net margin of 10.78% compared to Quanterix's net margin of -71.86%. Frequency Electronics' return on equity of 12.69% beat Quanterix's return on equity.

Company Net Margins Return on Equity Return on Assets
Frequency Electronics10.78% 12.69% 7.84%
Quanterix -71.86%-23.92%-17.66%

Frequency Electronics has a beta of 0.67, meaning that its stock price is 33% less volatile than the broader market. Comparatively, Quanterix has a beta of 1.14, meaning that its stock price is 14% more volatile than the broader market.

Frequency Electronics currently has a consensus price target of $43.67, suggesting a potential downside of 34.00%. Quanterix has a consensus price target of $4.00, suggesting a potential downside of 9.91%. Given Quanterix's higher probable upside, analysts clearly believe Quanterix is more favorable than Frequency Electronics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Frequency Electronics
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00
Quanterix
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

Frequency Electronics has higher earnings, but lower revenue than Quanterix. Quanterix is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Frequency Electronics$69.81M9.33$23.69M$0.7588.22
Quanterix$138.90M1.51-$107.15M-$2.36N/A

In the previous week, Quanterix had 1 more articles in the media than Frequency Electronics. MarketBeat recorded 2 mentions for Quanterix and 1 mentions for Frequency Electronics. Frequency Electronics' average media sentiment score of 1.89 beat Quanterix's score of 0.94 indicating that Frequency Electronics is being referred to more favorably in the media.

Company Overall Sentiment
Frequency Electronics Very Positive
Quanterix Positive

Summary

Frequency Electronics beats Quanterix on 12 of the 17 factors compared between the two stocks.

How does Quanterix compare to Cytek Biosciences?

Cytek Biosciences (NASDAQ:CTKB) and Quanterix (NASDAQ:QTRX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk and dividends.

Cytek Biosciences has higher revenue and earnings than Quanterix. Cytek Biosciences is trading at a lower price-to-earnings ratio than Quanterix, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cytek Biosciences$201.49M2.88-$66.54M-$0.57N/A
Quanterix$138.90M1.51-$107.15M-$2.36N/A

69.5% of Cytek Biosciences shares are held by institutional investors. Comparatively, 86.5% of Quanterix shares are held by institutional investors. 10.4% of Cytek Biosciences shares are held by insiders. Comparatively, 1.5% of Quanterix shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Cytek Biosciences has a net margin of -36.25% compared to Quanterix's net margin of -71.86%. Cytek Biosciences' return on equity of -10.07% beat Quanterix's return on equity.

Company Net Margins Return on Equity Return on Assets
Cytek Biosciences-36.25% -10.07% -7.56%
Quanterix -71.86%-23.92%-17.66%

In the previous week, Cytek Biosciences and Cytek Biosciences both had 2 articles in the media. Cytek Biosciences' average media sentiment score of 1.23 beat Quanterix's score of 0.94 indicating that Cytek Biosciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cytek Biosciences
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Quanterix
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cytek Biosciences has a beta of 1.18, meaning that its stock price is 18% more volatile than the broader market. Comparatively, Quanterix has a beta of 1.14, meaning that its stock price is 14% more volatile than the broader market.

Cytek Biosciences presently has a consensus price target of $5.69, suggesting a potential upside of 26.53%. Quanterix has a consensus price target of $4.00, suggesting a potential downside of 9.91%. Given Cytek Biosciences' stronger consensus rating and higher possible upside, research analysts clearly believe Cytek Biosciences is more favorable than Quanterix.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cytek Biosciences
1 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.33
Quanterix
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

Summary

Cytek Biosciences beats Quanterix on 13 of the 15 factors compared between the two stocks.

How does Quanterix compare to Syntec Optics?

Syntec Optics (NASDAQ:OPTX) and Quanterix (NASDAQ:QTRX) are both small-cap measuring and control equipment companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation.

Syntec Optics has higher earnings, but lower revenue than Quanterix. Syntec Optics is trading at a lower price-to-earnings ratio than Quanterix, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Syntec Optics$28.08M18.25-$1.79M-$0.08N/A
Quanterix$138.90M1.51-$107.15M-$2.36N/A

Quanterix has a consensus price target of $4.00, indicating a potential downside of 9.91%. Given Quanterix's stronger consensus rating and higher possible upside, analysts clearly believe Quanterix is more favorable than Syntec Optics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Syntec Optics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Quanterix
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

86.5% of Quanterix shares are held by institutional investors. 0.8% of Syntec Optics shares are held by insiders. Comparatively, 1.5% of Quanterix shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Syntec Optics has a beta of -0.82, meaning that its share price is 182% less volatile than the broader market. Comparatively, Quanterix has a beta of 1.14, meaning that its share price is 14% more volatile than the broader market.

Syntec Optics has a net margin of -10.95% compared to Quanterix's net margin of -71.86%. Quanterix's return on equity of -23.92% beat Syntec Optics' return on equity.

Company Net Margins Return on Equity Return on Assets
Syntec Optics-10.95% -30.86% -12.35%
Quanterix -71.86%-23.92%-17.66%

In the previous week, Syntec Optics had 1 more articles in the media than Quanterix. MarketBeat recorded 3 mentions for Syntec Optics and 2 mentions for Quanterix. Syntec Optics' average media sentiment score of 1.29 beat Quanterix's score of 0.94 indicating that Syntec Optics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Syntec Optics
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Quanterix
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Quanterix beats Syntec Optics on 8 of the 15 factors compared between the two stocks.

How does Quanterix compare to 908 Devices?

908 Devices (NASDAQ:MASS) and Quanterix (NASDAQ:QTRX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

In the previous week, 908 Devices had 2 more articles in the media than Quanterix. MarketBeat recorded 4 mentions for 908 Devices and 2 mentions for Quanterix. Quanterix's average media sentiment score of 0.94 beat 908 Devices' score of 0.47 indicating that Quanterix is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
908 Devices
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Quanterix
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

88.1% of 908 Devices shares are held by institutional investors. Comparatively, 86.5% of Quanterix shares are held by institutional investors. 28.2% of 908 Devices shares are held by company insiders. Comparatively, 1.5% of Quanterix shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

908 Devices has higher earnings, but lower revenue than Quanterix. 908 Devices is trading at a lower price-to-earnings ratio than Quanterix, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
908 Devices$56.20M5.97$19.49M-$1.00N/A
Quanterix$138.90M1.51-$107.15M-$2.36N/A

908 Devices has a beta of 0.63, indicating that its stock price is 37% less volatile than the broader market. Comparatively, Quanterix has a beta of 1.14, indicating that its stock price is 14% more volatile than the broader market.

908 Devices presently has a consensus target price of $12.00, indicating a potential upside of 35.27%. Quanterix has a consensus target price of $4.00, indicating a potential downside of 9.91%. Given 908 Devices' stronger consensus rating and higher possible upside, research analysts clearly believe 908 Devices is more favorable than Quanterix.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
908 Devices
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Quanterix
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

908 Devices has a net margin of -62.40% compared to Quanterix's net margin of -71.86%. 908 Devices' return on equity of -14.03% beat Quanterix's return on equity.

Company Net Margins Return on Equity Return on Assets
908 Devices-62.40% -14.03% -10.40%
Quanterix -71.86%-23.92%-17.66%

Summary

908 Devices beats Quanterix on 12 of the 16 factors compared between the two stocks.

Get Quanterix News Delivered to You Automatically

Sign up to receive the latest news and ratings for QTRX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QTRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QTRX vs. The Competition

MetricQuanterixMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$209.12M$8.36B$6.80B$12.55B
Dividend YieldN/A2.52%2.66%6.16%
P/E Ratio-1.8815.9627.4225.27
Price / Sales1.517.15542.60102.53
Price / CashN/A17.7648.5358.59
Price / Book0.703.5311.006.57
Net Income-$107.15M$226.25M$3.57B$336.82M
7 Day Performance17.46%1.75%2.69%2.31%
1 Month Performance26.86%-2.79%1.85%-0.12%
1 Year Performance-33.63%4.28%36.85%30.30%

Quanterix Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QTRX
Quanterix
1.7222 of 5 stars
$4.44
+2.8%
$4.00
-9.9%
-35.0%$209.12M$138.90MN/A460
SIBN
SiBone
2.4163 of 5 stars
$16.88
-2.6%
$23.00
+36.3%
-13.3%$768.57M$200.93MN/A350
FEIM
Frequency Electronics
0.9921 of 5 stars
$61.77
-1.2%
$43.67
-29.3%
+192.2%$615.32M$69.81M82.36200
CTKB
Cytek Biosciences
2.7841 of 5 stars
$4.34
-3.1%
$5.69
+31.0%
+30.3%$560.48M$204.17MN/A500
OPTX
Syntec Optics
0.4289 of 5 stars
$10.58
+0.2%
N/A+829.1%$425.36M$27.53MN/A3

Related Companies and Tools


This page (NASDAQ:QTRX) was last updated on 7/1/2026 by MarketBeat.com Staff.
From Our Partners